Product Details
1/EA
$1,684.29
In Stock
$1,684.29
Additional Information
| Product Name | Erbitux (cetuximab) Injection, 2 mg/mL, 50 mL Vial |
| Manufacturer | Eli Lilly |
| Generic/Active Ingredient | Cetuximab (Murine) |
| Route of Administration | Intravenous |
| Dose Form | Parenteral preparations |
| Strength | 2 mg / 1 mL |
| Container Type | Vial |
| Volume | 50 mL |
| Mechanism of Action | Cetuximab is a chimeric monoclonal antibody that binds the extracellular domain of EGFR and can trigger antibody-dependent cellular cytotoxicity against EGFR-expressing tumor cells. |
| Application | EGFR-Targeted Antineoplastic |
| Side Effects | Adverse events include infusion reactions, skin and mucous membrane reactions, electrolyte abnormalities, gastrointestinal upset, infection, fatigue, breathing problems, and eye irritation. |
| Storage | Discard product if it contains particulate matter, is cloudy, or discolored. Discard unused portion. Do not store for later use. Do not freeze. Do not shake. Preparations of product in infusion containers are stable up to 12 hours at 36°F to 46°F and up to 8 hours at 68°F to 77°F. Reconstituted product is stable for up to 8 hours at room temperature (77°F). Refrigerate at 36°F to 46°F. |
This description is for informational purposes only and is not clinical advice.
Frequently Asked Questions (FAQs)
The cost of ERBITUX SF 2MG/ML 50ML is $$1,684.29
ERBITUX SF 2MG/ML 50ML is manufactured by Eli Lilly.
You can purchase ERBITUX SF 2MG/ML 50ML on our website at https://supplies.pipelinemedical.com/product/detail/erbitux-sf-2mg-ml-50ml-643341